中华肝脏病杂志
中華肝髒病雜誌
중화간장병잡지
CHINESE JOURNAL OF HEPATOLOGY
2009年
4期
271-274
,共4页
何华%徐中南%蔡大川%赖宁%凌宁%曾维群%石小枫%赵有蓉%周智%张大志
何華%徐中南%蔡大川%賴寧%凌寧%曾維群%石小楓%趙有蓉%週智%張大誌
하화%서중남%채대천%뢰저%릉저%증유군%석소풍%조유용%주지%장대지
肝炎,乙型,慢性%肝炎病毒,乙型%DNA
肝炎,乙型,慢性%肝炎病毒,乙型%DNA
간염,을형,만성%간염병독,을형%DNA
Hepatitis B,chronic%Hepatitis B virus%DNA
目的 分析慢性乙型肝炎患者12周内自发性HBV DNA水平下降情况.方法 回顾性分析2003-2005年未接受抗病毒药物治疗的慢性乙型肝炎患者12周内自发性HBV DNA水平下降情况,并根据患者基线ALT、总胆红素(TBil)水平进行分组,分析基线ALT、TBil对自发性HBVDNA水平下降的影响.两组间计量资料比较采用t检验或Wilcoxon符号秩和检验;多组数据均值比较采用方差分析;组间率的比较采用x2检验.结果 共收集213例慢性乙型肝炎患者,男性174例,女性39例,年龄18~65(33.0±10.0)岁.其中慢性乙型肝炎轻~中度124例,慢性乙型肝炎重度89例;12周时失访19例(8.92%).所有患者HBV DNA基线均值为(6.66±1.03)log10拷贝/ml,12周时为(5.98±1.53)log10拷贝/ml(P<0.01).慢性乙型肝炎重度患者基线时HBVDNA水平均值低于慢性乙型肝炎轻~中度患者,分别为(6.45±0.99)log10拷贝/ml与(6.81±1.04)log10拷贝/ml(P<0.05);但两组12周时HBV DNA水平均值及HBV DNA水平下降值的差异均无统计学意义.12周时HBV DNA≤3 log10拷贝/ml患者的基线ALT及TBil值高于HBVDNA>3 log10拷贝/ml组,但差异均无统计学意义.12周时HBV DNA水平下降值≥2 log10拷贝/ml与<2 log10拷贝/ml两组患者的基线ALT、TBil水平相近(P>0.05).基线ALT水平≤5倍正常值上限(ULN)与>5×ULN两组患者12周时HBV DNA水平均值及HBV DNA水平下降值的差异均无统计学意义;两组患者12周时HBV DNA≤3 log10拷贝/ml、HBV DNA水平下降值≥2 log10拷贝/ml的比例,差异也无统计学意义(P>0.05).基线时ALT≤5 × ULN及TBil≤5×ULN组HBV DNA水平均值高于其他3组(P<0.05),但12周时各组HBV DNA水平均值、HBV DNA下降值比较,差异无统计学意义. 结论 慢性乙型肝炎患者12周内存在一定程度的自发性HBV DNA水平下降,但肝脏炎症损伤程度与患者12周内自发性HBV DNA水平下降程度无明显的相关性.
目的 分析慢性乙型肝炎患者12週內自髮性HBV DNA水平下降情況.方法 迴顧性分析2003-2005年未接受抗病毒藥物治療的慢性乙型肝炎患者12週內自髮性HBV DNA水平下降情況,併根據患者基線ALT、總膽紅素(TBil)水平進行分組,分析基線ALT、TBil對自髮性HBVDNA水平下降的影響.兩組間計量資料比較採用t檢驗或Wilcoxon符號秩和檢驗;多組數據均值比較採用方差分析;組間率的比較採用x2檢驗.結果 共收集213例慢性乙型肝炎患者,男性174例,女性39例,年齡18~65(33.0±10.0)歲.其中慢性乙型肝炎輕~中度124例,慢性乙型肝炎重度89例;12週時失訪19例(8.92%).所有患者HBV DNA基線均值為(6.66±1.03)log10拷貝/ml,12週時為(5.98±1.53)log10拷貝/ml(P<0.01).慢性乙型肝炎重度患者基線時HBVDNA水平均值低于慢性乙型肝炎輕~中度患者,分彆為(6.45±0.99)log10拷貝/ml與(6.81±1.04)log10拷貝/ml(P<0.05);但兩組12週時HBV DNA水平均值及HBV DNA水平下降值的差異均無統計學意義.12週時HBV DNA≤3 log10拷貝/ml患者的基線ALT及TBil值高于HBVDNA>3 log10拷貝/ml組,但差異均無統計學意義.12週時HBV DNA水平下降值≥2 log10拷貝/ml與<2 log10拷貝/ml兩組患者的基線ALT、TBil水平相近(P>0.05).基線ALT水平≤5倍正常值上限(ULN)與>5×ULN兩組患者12週時HBV DNA水平均值及HBV DNA水平下降值的差異均無統計學意義;兩組患者12週時HBV DNA≤3 log10拷貝/ml、HBV DNA水平下降值≥2 log10拷貝/ml的比例,差異也無統計學意義(P>0.05).基線時ALT≤5 × ULN及TBil≤5×ULN組HBV DNA水平均值高于其他3組(P<0.05),但12週時各組HBV DNA水平均值、HBV DNA下降值比較,差異無統計學意義. 結論 慢性乙型肝炎患者12週內存在一定程度的自髮性HBV DNA水平下降,但肝髒炎癥損傷程度與患者12週內自髮性HBV DNA水平下降程度無明顯的相關性.
목적 분석만성을형간염환자12주내자발성HBV DNA수평하강정황.방법 회고성분석2003-2005년미접수항병독약물치료적만성을형간염환자12주내자발성HBV DNA수평하강정황,병근거환자기선ALT、총담홍소(TBil)수평진행분조,분석기선ALT、TBil대자발성HBVDNA수평하강적영향.량조간계량자료비교채용t검험혹Wilcoxon부호질화검험;다조수거균치비교채용방차분석;조간솔적비교채용x2검험.결과 공수집213례만성을형간염환자,남성174례,녀성39례,년령18~65(33.0±10.0)세.기중만성을형간염경~중도124례,만성을형간염중도89례;12주시실방19례(8.92%).소유환자HBV DNA기선균치위(6.66±1.03)log10고패/ml,12주시위(5.98±1.53)log10고패/ml(P<0.01).만성을형간염중도환자기선시HBVDNA수평균치저우만성을형간염경~중도환자,분별위(6.45±0.99)log10고패/ml여(6.81±1.04)log10고패/ml(P<0.05);단량조12주시HBV DNA수평균치급HBV DNA수평하강치적차이균무통계학의의.12주시HBV DNA≤3 log10고패/ml환자적기선ALT급TBil치고우HBVDNA>3 log10고패/ml조,단차이균무통계학의의.12주시HBV DNA수평하강치≥2 log10고패/ml여<2 log10고패/ml량조환자적기선ALT、TBil수평상근(P>0.05).기선ALT수평≤5배정상치상한(ULN)여>5×ULN량조환자12주시HBV DNA수평균치급HBV DNA수평하강치적차이균무통계학의의;량조환자12주시HBV DNA≤3 log10고패/ml、HBV DNA수평하강치≥2 log10고패/ml적비례,차이야무통계학의의(P>0.05).기선시ALT≤5 × ULN급TBil≤5×ULN조HBV DNA수평균치고우기타3조(P<0.05),단12주시각조HBV DNA수평균치、HBV DNA하강치비교,차이무통계학의의. 결론 만성을형간염환자12주내존재일정정도적자발성HBV DNA수평하강,단간장염증손상정도여환자12주내자발성HBV DNA수평하강정도무명현적상관성.
Objective To analyze the spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks. Methods Chronic hepatitis B patients not receiving antiviral treatment from 2003 to 2005 were divided into two groups according to the baseline value of ALT and TBil. Spontaneous decline of HBV DNA were retrospected, and the influence of the baseline value of ALT and TBil on spontaneous decline of HBV DNA was analyzed. Results Total of 213 chronic hepatitis B patients (male 174, female 39, aged from 18 to 65) were recruited in this study, in cluding 124 mild and moderate type of hepatitis B, 89 severe type of hepatitis B, and 19 patients (8.92%) were lost at the end of the 12th week. The mean baseline value of HBV DNA of all the patients was (6.66 ± 1.03) logio copies/ml, at 12 week the mean value of HBV DNA of all the patients was (5.98 ± 1.53) logio copies/ml (compared to baseline P < 0.01), the decline value of HBV DNA was (0.68 ± 1.46) logio copies/ml.The mean baseline value of HBV DNA of patients with the severe type of hepatitis B was lower than that with the mild or moderate type of hepatitis B patients [(6.45 ± 0.99) logio copies/ml and (6.81 ± 1.04) log10 copies/ml respectively] (P < 0.05). However; there was no significant difference in the mean and the declined value of HBV DNA between these two groups at the 12th week (P > 0.05). At the 12th week, the baseline values of ALT and TBil were higher in patients with HBV DNA ≤3 logio copies/ml than those in patients with HBV DNA > 3 logio copies/ml (P > 0.05); And there were no significant difference in the baseline values of ALT and TBil between patients with the declined value of HBV DNA ≥ 2 logio copies/ml and patients with declined value of HBV DNA < 2 logio copies/ml. At the 12th week, the mean and the declined value of HBV DNA were similar between the patients with ALT ≤5 × ULN and the patients with ALT > 5 x ULN at baseline. The mean baseline value of HBV DNA of patients in the group of patients whose baseline value of ALT ≤ 5 × ULN while TBil ≤ 5×ULN was higher than that in the group of patients whose baseline value of ALT>5 × ULN while TBil > 5 × ULN, ALT ≤5 ×ULN while TBil>5×ULN,ALT>5 ×ULN while TBil ≤ 5 ×ULN (P < 0.05 respectively), there were no significant difference in the rate of the HBV DNA ≤ 3 logio copies/ml and the rate of the decling value of HBV DNA ≥ 2 logio copies/ml between the groups at 12 week (P > 0.05 respectively). Conclusions There is spontaneous decline of HBV DNA in patients with chronic hepatitis B in 12 weeks, but the level of liver injury is not correlated with the level of spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks.